CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-11 | MANUSO JAMES S J Director | Option exercise | +787 | $0.00 | $0 | 36,465 |
| 2022-10-11 | MANUSO JAMES S J Director | Option exercise · Series B Warrant (right to buy) | −787 | 0 | ||
| 2022-10-03 | Rodgers Richard J Director | Option exercise | +3,148 | $0.00 | $0 | 67,424 |
| 2022-10-03 | Rodgers Richard J Director | Option exercise · Series B Warrant (right to buy) | −3,148 | 0 | ||
| 2022-09-06 | Sooch Mina President and CEO | Option exercise | +1,023 | $0.00 | $0 | 426,045 |
| 2022-09-06 | Sooch Mina President and CEO | Option exercise · Series B Warrant (right to buy) | −1,023 | 0 | ||
| 2022-07-01 | Benton Susan Director | Grant or award | +6,335 | 38,790 | ||
| 2022-07-01 | Benton Susan Director | Grant or award | +12,376 | 51,166 | ||
| 2022-07-01 | Rodgers Richard J Director | Grant or award | +7,812 | 48,435 | ||
| 2022-07-01 | Rodgers Richard J Director | Grant or award | +15,841 | 64,276 | ||
| 2022-07-01 | MANUSO JAMES S J Director | Grant or award | +14,108 | 35,678 | ||
| 2022-07-01 | Pepose Jay Director | Grant or award | +9,900 | 32,894 | ||
| 2022-06-13 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-13 | Gallagher Cam Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-13 | MANUSO JAMES S J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-13 | Benton Susan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-13 | Pepose Jay Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-13 | Ainsworth Sean Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-20 | MANUSO JAMES S J Director | Purchase | +5,000 | $1.99 | $10K | 21,570 |
| 2022-05-20 | Sooch Mina President and CEO | Purchase | +12,500 | $2.02 | $25K | 425,022 |
Page 10 of 15 · 283 trades